José Cerbino-Neto

7.5k total citations
31 papers, 307 citations indexed

About

José Cerbino-Neto is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, José Cerbino-Neto has authored 31 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 12 papers in Public Health, Environmental and Occupational Health and 11 papers in Epidemiology. Recurrent topics in José Cerbino-Neto's work include Mosquito-borne diseases and control (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 epidemiological studies (5 papers). José Cerbino-Neto is often cited by papers focused on Mosquito-borne diseases and control (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 epidemiological studies (5 papers). José Cerbino-Neto collaborates with scholars based in Brazil, Spain and United States. José Cerbino-Neto's co-authors include Guilherme Loureiro Werneck, Carlos Henrique Nery Costa, Yasmine Rangel Vieira, Giselle Barbosa-Lima, Thiago Moreno L. Souza, Patrı́cia T. Bozza, Fernando A. Bozza, M.V.N. De Souza, Gerson Oliveira Penna and Emersom Cicilini Mesquita and has published in prestigious journals such as PLoS ONE, Emerging infectious diseases and Journal of General Virology.

In The Last Decade

José Cerbino-Neto

28 papers receiving 302 citations

Peers

José Cerbino-Neto
W. Kizito France
Joshua M. Wong United States
Pamela Das South Africa
José Cerbino-Neto
Citations per year, relative to José Cerbino-Neto José Cerbino-Neto (= 1×) peers Pritu Dhalaria

Countries citing papers authored by José Cerbino-Neto

Since Specialization
Citations

This map shows the geographic impact of José Cerbino-Neto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Cerbino-Neto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Cerbino-Neto more than expected).

Fields of papers citing papers by José Cerbino-Neto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Cerbino-Neto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Cerbino-Neto. The network helps show where José Cerbino-Neto may publish in the future.

Co-authorship network of co-authors of José Cerbino-Neto

This figure shows the co-authorship network connecting the top 25 collaborators of José Cerbino-Neto. A scholar is included among the top collaborators of José Cerbino-Neto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Cerbino-Neto. José Cerbino-Neto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Wonyeong, Dansu Yuan, Benjamin P. Kellman, et al.. (2024). Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike. npj Vaccines. 9(1). 7–7. 2 indexed citations
2.
Cerbino-Neto, José, et al.. (2024). Casos notificados de mpox na cidade do Rio de Janeiro, Brasil: estudo descritivo, 2022. Epidemiologia e Serviços de Saúde. 33. 1 indexed citations
3.
Aguilar, Soraida, Leonardo dos Santos Lourenço Bastos, Paula Maçaira, et al.. (2024). Impact of the first year of COVID-19 vaccination strategy in Brazil: an ecological study. BMJ Open. 14(7). e072314–e072314.
4.
Lemos, Alberto dos Santos de, et al.. (2023). Hepatitis A seroprevalence among special populations in the Rio de Janeiro Metropolitan Area, Brazil. Cadernos de Saúde Pública. 39(2). e00075522–e00075522.
5.
Silva, Ivan Da, Mayara Secco Torres Silva, Grazielle Viana Ramos, et al.. (2023). Clinical features, etiologies, and outcomes of central nervous system infections in intensive care: A multicentric retrospective study in a large Brazilian metropolitan area. Journal of Critical Care. 79. 154451–154451. 1 indexed citations
6.
Lemos, Alberto dos Santos de, et al.. (2022). Telemedicine in the National Immunization Program (Brazil): A promising tool. Vaccine X. 11. 100188–100188. 2 indexed citations
7.
Cerbino-Neto, José, Igor Tona Peres, Luiz Felipe Pinto, et al.. (2022). Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response. Frontiers in Public Health. 10. 1017337–1017337.
8.
Ranzani, Otávio T., Igor Tona Peres, Daniel Soranz, et al.. (2022). Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study. Clinical Microbiology and Infection. 28(5). 736.e1–736.e4. 9 indexed citations
9.
Moreira, Jéssica Pronestino de Lima, et al.. (2022). Antibiotic Consumption and Deviation of Prescribed Daily Dose From the Defined Daily Dose in Critical Care Patients: A Point-Prevalence Study. Frontiers in Pharmacology. 13. 913568–913568. 12 indexed citations
10.
Silva, Ivan Da, Mayara Secco Torres Silva, Grazielle Viana Ramos, et al.. (2021). Central nervous system infection in the intensive care unit: Development and validation of a multi-parameter diagnostic prediction tool to identify suspected patients. PLoS ONE. 16(11). e0260551–e0260551. 3 indexed citations
11.
Lemos, Alberto dos Santos de, et al.. (2020). Seroprevalence of varicella antibodies in adults without clinical history of disease. Cadernos de Saúde Pública. 36(1). e00149119–e00149119. 1 indexed citations
12.
Penna, Gerson Oliveira, et al.. (2020). PNAD COVID-19: um novo e poderoso instrumento para Vigilância em Saúde no Brasil. Ciência & Saúde Coletiva. 25(9). 3567–3571. 9 indexed citations
13.
Delatorre, Edson, Milene Dias Miranda, Diogo A. Tschoeke, et al.. (2018). An observational clinical case of Zika virus-associated neurological disease is associated with primary IgG response and enhanced TNF levels. Journal of General Virology. 99(7). 913–916. 3 indexed citations
14.
Passos, Sônia Regina Lambert, Maria Angélica Borges dos Santos, José Cerbino-Neto, et al.. (2017). Detection of Zika Virus in April 2013 Patient Samples, Rio de Janeiro, Brazil. Emerging infectious diseases. 23(12). 2120–2121. 21 indexed citations
15.
Barbosa-Lima, Giselle, Carlos R. Kaiser, J.L. Wardell, et al.. (2017). N -(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity. European Journal of Medicinal Chemistry. 127. 434–441. 20 indexed citations
16.
Amâncio, Rodrigo T., Camila Maria Beder Ribeiro Girish Panjwani, Emersom Cicilini Mesquita, et al.. (2016). Six-month survival of critically ill patients with HIV-related disease and tuberculosis: a retrospective study. BMC Infectious Diseases. 16(1). 270–270. 12 indexed citations
17.
Barbosa-Lima, Giselle, Caroline S. de Freitas, Yasmine Rangel Vieira, et al.. (2016). 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine. European Journal of Medicinal Chemistry. 127. 334–340. 51 indexed citations
18.
Cerbino-Neto, José. (2014). Ethical issues in the management of patients with Ebola virus disease. Cadernos de Saúde Pública. 30(11). 2256–2258. 3 indexed citations
19.
Cerbino-Neto, José, Gerson Oliveira Penna, & Guilherme Loureiro Werneck. (2013). Regional differences in mortality associated with pandemic Influenza A H1N1 in Brazil. Cadernos de Saúde Pública. 29(1). 189–194. 6 indexed citations
20.
Suarez‐Kurtz, Guilherme, et al.. (2006). Limited Penetration of Lopinavir and Ritonavir in the Genital Tract of Men Infected with HIV-1 in Brazil. Therapeutic Drug Monitoring. 28(2). 175–179. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026